Healthcare Insider Buying: Opko Health (NYSE:OPK), American Apparel (NYSEMKT:APP), Accelerate Diagnostics Inc (NASDAQ:AXDX), Biota Pharmaceuticals Inc (NASDAQ:BOTA), Echo Therapeutics Inc (NASDAQ:ECTE)

Technology Stocks News 1

Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost purchased 30,000 shares of the stock in a transaction dated Tuesday, July 8th. The shares were purchased at an average price of $8.58 per share, for a total transaction of $257,400.00. Following the completion of the transaction, the chief executive officer now directly owns 1,987,500 shares in the company, valued at approximately $17,052,750. Opko Health Inc. (NYSE:OPK) stock performance was 1.64% in last session and finished the day at $8.70. Traded volume was 2.02million shares in the last session and the average volume of the stock remained 2.50million shares. The beta of the stock remained 1.09. Opko Health Inc. (NYSE:OPK) insider ownership is 6.90%.

American Apparel Inc (NYSEMKT:APP) CEO Dov Charney bought 27,351,407 shares of American Apparel stock in a transaction that occurred on Friday, June 27th. The stock was purchased at an average cost of $0.72 per share, with a total value of $19,693,013.04. Following the acquisition, the chief executive officer now directly owns 74,560,813 shares in the company, valued at approximately $53,683,785. American Apparel Inc (NYSEMKT:APP) rose 1.12 percent to $0.850 Wednesday on volume of 3.47million shares. The intra-day range of the stock was $0.81 to $0.87. American Apparel Inc (NYSEMKT:APP)  has a market capitalization of $147.39million.

Accelerate Diagnostics (NASDAQ:AXDX) Director Jack W. Schuler purchased 8,698 shares of the company’s stock on the open market in a transaction dated Tuesday, July 1st. The shares were purchased at an average price of $25.70 per share, with a total value of $223,538.60. Accelerate Diagnostics Inc (NASDAQ:AXDX)’s stock on July 09, 2014 reported a increase of 1.98% to the closing price of $25.81. Its fifty two weeks range is $6.86 -$31.86. The total market capitalization recorded $1.15billion. The overall volume in the last trading session was 139,222.00million shares. In its share capital, AXDX has 44.58million outstanding shares.

Biota Pharmaceuticals (NASDAQ:BOTA) CEO Russell H. Plumb purchased 32,031 shares of the stock on the open market in a transaction that occurred on Wednesday, June 11th. The shares were purchased at an average price of $2.99 per share, for a total transaction of $95,772.69. Following the acquisition, the chief executive officer now directly owns 127,579 shares of the company’s stock, valued at approximately $381,461. On Wednesday, shares of Biota Pharmaceuticals Inc (NASDAQ:BOTA) advanced 2.39% to close the day at $3.00. Company return on investment (ROI) is -21.20% and its monthly performance is recorded as 23.97%. Biota Pharmaceuticals Inc (NASDAQ:BOTA) quarterly revenue growth is -47.09%.

Echo Therapeutics (NASDAQ:ECTE) major shareholder Mark Nordlicht acquired 65,739 shares of the company’s stock on the open market in a transaction that occurred on Monday, June 30th. The stock was purchased at an average price of $2.20 per share, for a total transaction of $144,625.80. Echo Therapeutics Inc (NASDAQ:ECTE) stock finished the day at $2.11. Traded volume was 55,225.00million shares in the last session and the average volume of the stock remained 108.87K shares. The beta of the stock remained 1.13. Echo Therapeutics Inc (NASDAQ:ECTE) insider ownership is 0.10%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone